Turning $2 into $20,000 has never been easier — if you’re lucky. Some uncirculated U.S. $2 bills may be worth up to $20,000, but it depends on a few factors, according to Heritage Auctions, one of the ...

Zemprocitinib, a next-generation JAK1 inhibitor, may tame rheumatoid arthritis that does not respond to at least one biologic disease-modifying antirheumatic drug, a phase 3 clinical trial finds.

BACKGROUND: Congenital heart disease (CHD), the most common birth defect and a leading cause of infant mortality, is ...

Key Points Interested in Aclaris Therapeutics, Inc.? Here are five stocks we like better. Aclaris Therapeutics is preparing a ...

An intravitreal insert provides durable control of multiple retinal diseases, according to a presentation at Retina World ...

Epidemiology links AA and atopy: up to 40% of AA patients have atopic comorbidities, and concurrent AD predicts poorer response and relapse. Immune profiling shows mixed Th1/Th2/Th22 activation with ...

Livedoid vasculopathy was diagnosed. After treatment with tofacitinib combined with topical Hirudoid and Jinyin Peptide, the lesions healed. Livedoid vasculopathy (LV) is a rare, recurrent, and ...

Fluffy on the inside, crispy and golden on the outside, these featherlight biscuits deliver classic Southern-style flavor. What could be easier than two-ingredient biscuits? As the name indicates, ...

New immunologic and biomarker data supports the potential of ITK inhibition with soquelitinib to increase persistent Treg cells and influence ...

Deal gives Vyome entry into the fast-growing market for next-generation autoimmune and inflammatory disease drugs ...